Publications in collaboration with researchers from AstraZeneca (United Kingdom) (1)

2020

  1. Combined MEK and PI3K/p110β inhibition as a novel targeted therapy for malignant mesothelioma displaying sarcomatoid features

    Cancer Research, Vol. 80, Núm. 4, pp. 843-856